BI
BVF Inc’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $932M | Hold |
19,751,284
| – | – | 33.31% | 1 |
|
|
2025
Q1 | $772M | Hold |
19,751,284
| – | – | 31.45% | 1 |
|
|
2024
Q4 | $1.07B | Sell |
19,751,284
-2,000,000
| -9% | -$108M | 36.25% | 1 |
|
|
2024
Q3 | $1.1B | Hold |
21,751,284
| – | – | 32.08% | 1 |
|
|
2024
Q2 | $956M | Hold |
21,751,284
| – | – | 26.81% | 1 |
|
|
2024
Q1 | $1.09B | Hold |
21,751,284
| – | – | 30.04% | 1 |
|
|
2023
Q4 | $1.31B | Hold |
21,751,284
| – | – | 32.87% | 1 |
|
|
2023
Q3 | $1.24B | Hold |
21,751,284
| – | – | 33.43% | 1 |
|
|
2023
Q2 | $1.11B | Hold |
21,751,284
| – | – | 30.92% | 1 |
|
|
2023
Q1 | $465M | Hold |
21,751,284
| – | – | 17.01% | 1 |
|
|
2022
Q4 | $228M | Hold |
21,751,284
| – | – | 9.64% | 1 |
|
|
2022
Q3 | $173M | Hold |
21,751,284
| – | – | 7.15% | 1 |
|
|
2022
Q2 | $114M | Buy |
+21,751,284
| New | +$114M | 5.52% | 2 |
|